| 注册
首页|期刊导航|中国药物经济学|比较视角下广东省生物医药产业集群竞争力分析和发展模式探索

比较视角下广东省生物医药产业集群竞争力分析和发展模式探索

李伊玲 黄慧莹 黄满东 张秋

中国药物经济学2024,Vol.19Issue(3):31-36,45,7.
中国药物经济学2024,Vol.19Issue(3):31-36,45,7.DOI:10.12010/j.issn.1673-5846.2024.03.005

比较视角下广东省生物医药产业集群竞争力分析和发展模式探索

Comparative Competitiveness of Biomedical Industry Clusters in Guangdong Province and Exploration of Development Model based on Entropy Value Method

李伊玲 1黄慧莹 2黄满东 2张秋2

作者信息

  • 1. 广东药科大学医药化工学院,广州 510006
  • 2. 广东药科大学医药商学院,广州 510006
  • 折叠

摘要

Abstract

Objective To explore the competitiveness and future development model of Guangdong biomedical industry cluster.Methods Based on the entropy value method,we constructed a comprehensive evaluation index system for the competitiveness of biopharmaceutical industry clusters consisting of scale,operation,green technological innovation and growth competitiveness,analyzed the current situation of the development of the competitiveness of biopharmaceutical industry clusters in Guangdong Province from 2010 to 2020,and selected biopharmaceutical industry clusters in Zhejiang Province for the comparison.Results 2010-2020,the development trend of competitiveness of biopharmaceutical industry cluster in Guangdong Province was similar to that of Zhejiang Province,but all the competitiveness indicators were lower than Zhejiang Province,among which the competitiveness of green technology innovation had the biggest gap with Zhejiang.Conclusion The future development mode of Guangdong biomedical industry cluster should be oriented to"chain",stabilize the advantageous foundation of policy,service and financial chain,strengthen the backbone role of talent chain,and drive the high-quality development of industry chain by the innovation chain with the core of green technology innovation.

关键词

生物医药/产业集群竞争力/广东省/模式

Key words

Biomedical industry/Industry cluster competitiveness/Guangdong province/Model

分类

医药卫生

引用本文复制引用

李伊玲,黄慧莹,黄满东,张秋..比较视角下广东省生物医药产业集群竞争力分析和发展模式探索[J].中国药物经济学,2024,19(3):31-36,45,7.

基金项目

2022年第八届国家级大学生创新创业训练计划平台省级项目(202210573029)、广东省普通高校创新团队—卫生经济与社会保障研究创新团队(2022WCXTD011) (202210573029)

中国药物经济学

1673-5846

访问量0
|
下载量0
段落导航相关论文